- $6.93bn
- $9.77bn
- $7.35bn
- 74
- 84
- 44
- 75
R2019 December 31st | 2020 December 31st | R2021 December 31st | C2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Total Premiums Earned | |||||
Net Investment Income | |||||
Realized & Unrealized Gains / Losses | |||||
Total Revenue | 7,542 | 7,730 | 4,174 | 5,930 | 7,348 |
Losses, Benefits, and Adjustments | |||||
Amortization of Policy Acquisition Costs | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 6,756 | 7,192 | 865 | 5,319 | 6,372 |
Operating Profit | 786 | 538 | 3,309 | 611 | 976 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 574 | 352 | 3,085 | 428 | 678 |
Provision for Income Taxes | |||||
Net Income After Taxes | 791 | 370 | 3,119 | 433 | 729 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -360 | -206 | 2,370 | 510 | 625 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -388 | -242 | 2,334 | 474 | 589 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 5.88 | 3.9 | 12.8 | 5.75 | 7.44 |
Dividends per Share |